慢性炎症性脱髄性多発神経炎(CIDP)：グローバル臨床試験レビュー（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to Central Nervous System Clinical Trials 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
CSL Limited 30
Clinical Trial Overview of CSL Limited 30
LFB S.A. 31
Clinical Trial Overview of LFB S.A. 31
Biogen Idec Inc. 32
Clinical Trial Overview of Biogen Idec Inc. 32
Takeda Pharmaceutical Company Limited 33
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 33
Octapharma AG 34
Clinical Trial Overview of Octapharma AG 34
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
Kedrion S.p.A. 36
Clinical Trial Overview of Kedrion S.p.A. 36
Grifols, S.A. 37
Clinical Trial Overview of Grifols, S.A. 37
Grifols Deutschland Gmbh 38
Clinical Trial Overview of Grifols Deutschland Gmbh 38
GeNeuro SA 39
Clinical Trial Overview of GeNeuro SA 39
Clinical Trial Overview of Top Institutes / Government 40
National Center for Research Resources 40
Clinical Trial Overview of National Center for Research Resources 40
Aarhus University 41
Clinical Trial Overview of Aarhus University 41
Erasmus MC 42
Clinical Trial Overview of Erasmus MC 42
State University of New York at Buffalo 43
Clinical Trial Overview of State University of New York at Buffalo 43
Stony Brook University 44
Clinical Trial Overview of Stony Brook University 44
University of Cologne 45
Clinical Trial Overview of University of Cologne 45
Northwestern University 46
Clinical Trial Overview of Northwestern University 46
Centre Hospitalier Universitaire de Saint Etienne 47
Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne 47
Oregon Health and Science University 48
Clinical Trial Overview of Oregon Health and Science University 48
Rigshospitalet 49
Clinical Trial Overview of Rigshospitalet 49
Five Key Clinical Profiles 50
Appendix 92
Abbreviations 92
Definitions 92
Research Methodology 93
Secondary Research 93
About GlobalData 94
Contact Us 94
Disclaimer 94
Source 94